Clinical study of dental implant treatment for patients taking bone resorption inhibitors and angiogenesis inhibitors

Clinical study of dental implant treatment for patients taking bone resorption inhibitors and angiogenesis inhibitors - Clinical study of dental implant treatment for patients taking bone resorption inhibitors and angiogenesis inhibitors

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000047778

Enrollment

Registered

2022-05-17

Start date

2020-08-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

missing teeth

Interventions

no Intervention

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who have a history of oral administration of bone resorption inhibitors and angiogenesis inhibitors and wish to receive dental implant treatment and can collaborate in research.

Exclusion criteria

Exclusion criteria: Patients who are considered to have physical difficulty in implanting dental implants due to absorption of the ridge. Other patients who are considered to prefer prosthetic treatment with dentures or bridges rather than dental implant treatment.

Design outcomes

Primary

Measure	Time frame
The PDI (probing pocket depth) around the dental implant after implantation is measured to evaluate the inflammation of the surrounding gingiva. In addition, the presence or absence of exposed bone drainage is evaluated from macroscopic findings.	—

Countries

Japan

Contacts

Public Contactkazuya inoue

osaka medical and Pharmaceutical University oral surgery

kazuya.inoue@ompu.ac.jp0726831221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026